Juli LeDoux

Juli LeDoux joined AbbVie (previously ImmunoGen) in June of 2022 as the Director of Patient Marketing, providing strategic development of all patient-focused materials and education, including a focus on partnering with patient advocacy groups. She came from Biogen, where she served as the branded DTC lead for the launch of the first FDA-approved Alzheimer’s treatment. In addition, she was responsible for HCP and DTC marketing strategy and campaign development for the launch of Vumerity and ongoing support for Tecfidera, both in the MS space. Juli was key in exploring a renewed focus on multicultural audiences, robust media planning and measurement, and insight driven campaign development. Before coming to Biogen, Juli worked at Visual IQ, a marketing attribution company, helping guide clients across industries utilize data to improve their ROI. Prior to that, Juli led strategic cross-channel media planning and buying at agencies in both NYC and Boston for clients such as Oreo, Ritz, AT&T, and Lenovo. She has a BA from New York University and an MBA from Syracuse University. In her free time, she enjoys performing in musical theater and spending time with her family.